Dudediligence.

IQVIA Holdings Inc

IQVNYSE · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.90BSep ’24$3.96BDec ’24$3.83BMar ’25$4.02BJun ’25$4.10BSep ’25$4.36BDec ’25$4.15BMar ’26$4.37BJun ’26
Net income, by quarter
$285.0MSep ’24$437.0MDec ’24$249.0MMar ’25$266.0MJun ’25$331.0MSep ’25$514.0MDec ’25$274.0MMar ’26$256.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$13.87B$14.41B$14.98B$15.40B$16.31B
Operating income$1.39B$1.80B$1.98B$2.20B$2.18B
Net income$966.0M$1.09B$1.36B$1.37B$1.36B
Operating cash flow$2.94B$2.26B$2.15B$2.72B$2.65B
Free cash flow$2.30B$1.59B$1.50B$2.11B$2.05B
Cash$1.37B$1.22B$1.38B$1.70B$1.98B
Debt$12.13B$12.75B$13.67B$13.98B$15.72B
Shares outstanding190.6M185.7M181.5M176.1M169.6M